| Name | Unterstützung | Language | Verfügbarkeit | Datum der Ausstellung | Preis | ||
|---|---|---|---|---|---|---|---|
|
PDF |
Englisch |
gültig |
01.10.2011 |
193,00 € |
|
||
Details
Antimicrobial susceptibility testing is indicated for any organism that contributes to an infectious process warranting
antimicrobial chemotherapy, if its susceptibility cannot be reliably predicted from knowledge of the organism?s identity.
Standardized in vitro antimicrobial susceptibility tests are also needed in order to evaluate new antimicrobials against specific
groups of organisms in comparison with existing agents. Acquired resistance to one or more classes of antimicrobial agents has
now emerged in the major mycoplasmal and ureaplasmal species that infect humans, hence the need to establish accurate and
reproducible methods to measure antimicrobial activities in vitro with these organisms.
This document provides guidelines for performance, interpretation, and quality control of in vitro broth microdilution and agar
dilution susceptibility tests for several antimicrobial agents suitable for use against Mycoplasma pneumoniae (M. pneumoniae),
Mycoplasma hominis (M. hominis), and Ureaplasma species (Ureaplasma spp). Information in this document includes
designated reference strains and the expected minimal inhibitory concentration ranges for specific drugs that should be obtained
when they are tested.
Zusätzliche Information
| Autor | Clinical and Laboratory Standards Institute (CLSI) |
|---|---|
| Veröffentlicht von | CLSI |
| Document type | Normen |
| Thema | /subgroups/17907 |
| EAN ISBN | 1562387693, 1562387707 |
| Seitenzahl | 52 |
| Schlagwort | CLSI M43-A |
